Skip to content

Effects of aromatherapy massage with Cinnamomum sintoc essential oil for myofascial pain syndrome

Effects of aromatherapy massage with Cinnamomum sintoc essential oil for myofascial pain syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250402002
Enrollment
70
Registered
2025-04-02
Start date
2023-03-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain syndrome (MPS) associated with the trapezius muscle Cinnamomum sintoc essential oil Aromatherapy massage Myofascial pain syndrome (MPS) Trapezius muscle

Interventions

Aromatherapy massage with C. sintoc essential oil (20 ml of 3% C. sintoc oil mixed with lemongrass oil and vetiver oil),Aromatherapy massage with base oil (20 ml of the base oil in the coconut oil and
Experimental Other,Placebo Comparator Other
aromatherapy massage with C. sintoc essential oil,Aromatherapy massage without C. sintoc essential oil

Sponsors

Faculty of Traditional Thai Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Myofascial pain syndrome (MPS) associated with the trapezius muscle, as confirmed by a Thai Traditional Medicine doctor 2. Undergoing unilateral or bilateral upper trapezius MPS with a pain level of 4-6 (moderate) on a visual analogue scale 3. Willingness to participate in the study 4. Ability to communicate and respond to inquiries 5. Absence of shoulder dysfunction, cervical spine degeneration, cervical nerve root irritation, and severe rheumatoid arthritis 6. No history of allergies or sensitivities to herbal components, absence of acute infection symptoms in the back and shoulder muscles, no olfactory impairments, no history of asthma, and no prior back surgery

Exclusion criteria

Exclusion criteria: 1. Fever, malignancy, prescription physiotherapy for back pain, hospitalization, allergic response to C. sintoc, pregnancy and lactation, and unwillingness to continue participation

Design outcomes

Primary

MeasureTime frame
Pain intensity 1, 3, 5, 12 days Visual Analogue Scale (VAS) and Thai Short-Form McGill Pain Questionnaire (Th-SFMPQ)

Secondary

MeasureTime frame
Functional ability and odor-related affective responses 1, 3, 5, 12 days pain threshold (PPT), cervical spine range of motion (CROM), shoulder flexibility, neck disability index (NDI), and Geneva emotion and odor scale (GEOS),Adverse events 1, 3, 5, 12 days adverse event form

Countries

Thailand

Contacts

Public ContactThanyaluck Siriyong

Faculty of Traditional Thai Medicine, Prince of Songkla University

thanyaluck.s@psu.ac.th074282719

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026